Company Name: Prana Biotechnology Limited

Prana Biotechnology Limited is engaged in the development of therapies for neurodegenerative diseases. The company’s lead product candidate is a treatment for Alzheimer’s and Huntington’s diseases.

Ticker Symbol: PRAN (NASDAQ)

Ticker Symbol: PBT (ASX)

Company Website: http://pranabio.com

Headquarters: Parkville, Victoria, Australia